CanniMed founder back with new Saskatoon-based venture

Brent Zettl remembers sitting at his desk, alone in an office with nothing but a laptop and a pen, trying to start all over again.
It was early April 2018 and the cannabis executive had just resigned as CEO of CanniMed Therapeutics Inc., the country’s first licensed medical marijuana producer, after it was acquired by Aurora Cannabis Inc. for $1.1 billion.
“Basically, the mission wasn’t complete. I may have sold the business, but the mission wasn’t complete,” Zettl